According to people familiar with the matter, the draft trade agreement between the US and Switzerland contains a provision that Switzerland will receive preferential treatment in ongoing national security investigations to avoid the imposition of tariffs on its pharmaceutical exports. This provision does not guarantee that Washington will delay imposing tariffs on the Swiss pharmaceutical industry, which is critical to Switzerland. They said the wording was to guarantee cooperation between the two parties and to avoid such actions through so-called Section 232 investigations. One of the people familiar with the matter said that the draft still requires Trump's nod, and the Swiss government has implicitly agreed. They added that as soon as the US President signs it, Switzerland will officially ratify it soon.

According to people familiar with the matter, the draft trade agreement between the US and Switzerland contains a provision that Switzerland will receive preferential treatment in ongoing national security investigations to avoid the imposition of tariffs on its pharmaceutical exports. This provision does not guarantee that Washington will delay imposing tariffs on the Swiss pharmaceutical industry, which is critical to Switzerland. They said the wording was to guarantee cooperation between the two parties and to avoid such actions through so-called Section 232 investigations. One of the people familiar with the matter said that the draft still requires Trump's nod, and the Swiss government has implicitly agreed. They added that as soon as the US President signs it, Switzerland will officially ratify it soon.